CA Stock MarketDetailed Quotes

PRN Profound Medical Corp

Watchlist
  • 6.560
  • -0.010-0.15%
15min DelayMarket Closed Apr 25 16:00 ET
197.15MMarket Cap-4.07P/E (TTM)

Profound Medical Corp Key Stats

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(FY)Dec 31, 2024
(Q4)Dec 31, 2024
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
Total revenue
48.35%10.68M
107.86%4.18M
63.89%2.83M
39.39%2.23M
-22.63%1.44M
7.75%7.2M
59.82%2.01M
-15.09%1.73M
-20.89%1.6M
36.36%1.86M
Operating revenue
48.35%10.68M
107.86%4.18M
63.89%2.83M
39.39%2.23M
-22.63%1.44M
7.75%7.2M
59.82%2.01M
-15.09%1.73M
-20.89%1.6M
36.36%1.86M
Cost of revenue
26.19%3.64M
25.41%1.21M
52.19%1.04M
42.96%812K
-13.83%573K
-21.12%2.89M
38.68%968K
-27.41%686K
-47.84%568K
-28.34%665K
Gross profit
63.20%7.04M
184.53%2.96M
71.59%1.79M
37.43%1.42M
-27.53%866K
42.73%4.31M
86.23%1.04M
-4.40%1.04M
10.47%1.03M
174.08%1.2M
Operating expense
21.65%40.1M
15.00%11.31M
41.72%10.79M
23.87%9.26M
8.72%8.74M
1.04%32.96M
43.39%9.83M
-18.37%7.61M
-14.18%7.48M
4.06%8.04M
Selling and administrative expenses
24.79%23.13M
13.73%6.66M
58.22%6.62M
17.33%5.06M
14.51%4.8M
3.38%18.54M
55.36%5.85M
-8.87%4.18M
-14.23%4.31M
-7.87%4.19M
Research and development costs
17.62%16.97M
16.87%4.65M
21.56%4.17M
32.78%4.21M
2.41%3.95M
-1.81%14.42M
28.78%3.98M
-27.59%3.43M
-14.13%3.17M
21.13%3.85M
Operating profit
-15.40%-33.06M
5.07%-8.35M
-36.98%-9M
-21.69%-7.84M
-15.04%-7.88M
3.21%-28.65M
-39.58%-8.79M
20.22%-6.57M
17.15%-6.44M
6.10%-6.85M
Net non-operating interest income (expenses)
85.29%1.44M
1,647.37%332K
-22.26%220K
33.54%422K
194.27%462K
-15.67%775K
100.57%19K
-91.35%283K
39.21%316K
153.23%157K
Total other finance cost
-85.29%-1.44M
-1,647.37%-332K
22.26%-220K
-33.54%-422K
-194.27%-462K
-167.24%-775K
---19K
---283K
-88.10%-316K
-256.82%-157K
Other net income (expenses)
762.26%3.81M
876.92%2.83M
-155.18%-410K
162.42%520K
819.01%870K
-291.03%-575K
-364K
743K
-150.89%-833K
87.32%-121K
Gain on sale of security
762.26%3.81M
876.92%2.83M
-155.18%-410K
162.42%520K
819.01%870K
-120.35%-575K
---364K
--743K
-150.89%-833K
87.32%-121K
Income before tax
2.22%-27.82M
43.25%-5.19M
-65.76%-9.19M
0.88%-6.9M
3.91%-6.55M
-0.24%-28.45M
1.98%-9.14M
-11.69%-5.54M
-17.70%-6.96M
16.78%-6.81M
Income tax
98.44%-2K
-3.93%-238K
883.33%177K
-45.71%19K
-16.67%40K
-144.60%-128K
-211.17%-229K
-47.06%18K
118.75%35K
54.84%48K
Earnings from equity interest net of tax
Net income
1.79%-27.82M
44.46%-4.95M
-68.40%-9.37M
1.10%-6.92M
3.99%-6.59M
1.21%-28.32M
6.51%-8.91M
-11.29%-5.56M
-17.98%-7M
16.51%-6.86M
Net income continuous operations
1.79%-27.82M
44.46%-4.95M
-68.40%-9.37M
1.10%-6.92M
3.99%-6.59M
1.21%-28.32M
6.51%-8.91M
-11.29%-5.56M
-17.98%-7M
16.51%-6.86M
Noncontrolling interests
Net income attributable to the company
1.79%-27.82M
44.46%-4.95M
-68.40%-9.37M
1.10%-6.92M
3.99%-6.59M
1.21%-28.32M
6.51%-8.91M
-11.29%-5.56M
-17.98%-7M
16.51%-6.86M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders
1.79%-27.82M
44.46%-4.95M
-68.40%-9.37M
1.10%-6.92M
3.99%-6.59M
1.21%-28.32M
6.51%-8.91M
-11.29%-5.56M
-17.98%-7M
16.51%-6.86M
Diluted earnings per share
16.42%-1.12
52.38%-0.2
-46.15%-0.38
15.15%-0.28
18.18%-0.27
2.90%-1.34
8.70%-0.42
-8.33%-0.26
-17.86%-0.33
17.50%-0.33
Basic earnings per share
16.42%-1.12
52.38%-0.2
-46.15%-0.38
15.15%-0.28
18.18%-0.27
2.90%-1.34
8.70%-0.42
-8.33%-0.26
-17.86%-0.33
17.50%-0.33
Dividend per share
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
Unqualified Opinion
--
--
--
--
Unqualified Opinion
--
--
--
--
(FY)Dec 31, 2024(Q4)Dec 31, 2024(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023
Total revenue 48.35%10.68M107.86%4.18M63.89%2.83M39.39%2.23M-22.63%1.44M7.75%7.2M59.82%2.01M-15.09%1.73M-20.89%1.6M36.36%1.86M
Operating revenue 48.35%10.68M107.86%4.18M63.89%2.83M39.39%2.23M-22.63%1.44M7.75%7.2M59.82%2.01M-15.09%1.73M-20.89%1.6M36.36%1.86M
Cost of revenue 26.19%3.64M25.41%1.21M52.19%1.04M42.96%812K-13.83%573K-21.12%2.89M38.68%968K-27.41%686K-47.84%568K-28.34%665K
Gross profit 63.20%7.04M184.53%2.96M71.59%1.79M37.43%1.42M-27.53%866K42.73%4.31M86.23%1.04M-4.40%1.04M10.47%1.03M174.08%1.2M
Operating expense 21.65%40.1M15.00%11.31M41.72%10.79M23.87%9.26M8.72%8.74M1.04%32.96M43.39%9.83M-18.37%7.61M-14.18%7.48M4.06%8.04M
Selling and administrative expenses 24.79%23.13M13.73%6.66M58.22%6.62M17.33%5.06M14.51%4.8M3.38%18.54M55.36%5.85M-8.87%4.18M-14.23%4.31M-7.87%4.19M
Research and development costs 17.62%16.97M16.87%4.65M21.56%4.17M32.78%4.21M2.41%3.95M-1.81%14.42M28.78%3.98M-27.59%3.43M-14.13%3.17M21.13%3.85M
Operating profit -15.40%-33.06M5.07%-8.35M-36.98%-9M-21.69%-7.84M-15.04%-7.88M3.21%-28.65M-39.58%-8.79M20.22%-6.57M17.15%-6.44M6.10%-6.85M
Net non-operating interest income (expenses) 85.29%1.44M1,647.37%332K-22.26%220K33.54%422K194.27%462K-15.67%775K100.57%19K-91.35%283K39.21%316K153.23%157K
Total other finance cost -85.29%-1.44M-1,647.37%-332K22.26%-220K-33.54%-422K-194.27%-462K-167.24%-775K---19K---283K-88.10%-316K-256.82%-157K
Other net income (expenses) 762.26%3.81M876.92%2.83M-155.18%-410K162.42%520K819.01%870K-291.03%-575K-364K743K-150.89%-833K87.32%-121K
Gain on sale of security 762.26%3.81M876.92%2.83M-155.18%-410K162.42%520K819.01%870K-120.35%-575K---364K--743K-150.89%-833K87.32%-121K
Income before tax 2.22%-27.82M43.25%-5.19M-65.76%-9.19M0.88%-6.9M3.91%-6.55M-0.24%-28.45M1.98%-9.14M-11.69%-5.54M-17.70%-6.96M16.78%-6.81M
Income tax 98.44%-2K-3.93%-238K883.33%177K-45.71%19K-16.67%40K-144.60%-128K-211.17%-229K-47.06%18K118.75%35K54.84%48K
Earnings from equity interest net of tax
Net income 1.79%-27.82M44.46%-4.95M-68.40%-9.37M1.10%-6.92M3.99%-6.59M1.21%-28.32M6.51%-8.91M-11.29%-5.56M-17.98%-7M16.51%-6.86M
Net income continuous operations 1.79%-27.82M44.46%-4.95M-68.40%-9.37M1.10%-6.92M3.99%-6.59M1.21%-28.32M6.51%-8.91M-11.29%-5.56M-17.98%-7M16.51%-6.86M
Noncontrolling interests
Net income attributable to the company 1.79%-27.82M44.46%-4.95M-68.40%-9.37M1.10%-6.92M3.99%-6.59M1.21%-28.32M6.51%-8.91M-11.29%-5.56M-17.98%-7M16.51%-6.86M
Preferred stock dividends
Other under preferred stock dividend
Net income attributable to common stockholders 1.79%-27.82M44.46%-4.95M-68.40%-9.37M1.10%-6.92M3.99%-6.59M1.21%-28.32M6.51%-8.91M-11.29%-5.56M-17.98%-7M16.51%-6.86M
Diluted earnings per share 16.42%-1.1252.38%-0.2-46.15%-0.3815.15%-0.2818.18%-0.272.90%-1.348.70%-0.42-8.33%-0.26-17.86%-0.3317.50%-0.33
Basic earnings per share 16.42%-1.1252.38%-0.2-46.15%-0.3815.15%-0.2818.18%-0.272.90%-1.348.70%-0.42-8.33%-0.26-17.86%-0.3317.50%-0.33
Dividend per share
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions Unqualified Opinion--------Unqualified Opinion--------

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights

Dividend Kings of Canada Dividend Kings of Canada

Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility. Dividend Kings In Canada are companies that have increased their Dividend per share for the most consecutive years, reflecting a strong business model and robust financials, and are likely to outperform the market with less volatility.

Unlock Now